http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA01012325-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 |
| filingDate | 2000-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_038818efe6295ac50df7b6b735b87843 |
| publicationDate | 2002-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-PA01012325-A |
| titleOfInvention | POLYMORPH FORMS OF A CRYSTALLINE CITRATE OF AZOBICICLO (2.2.2) OCTAN-3-AMINA AND ITS PHARMACEUTICAL COMPOSITIONS. |
| abstract | An individual crystalline polymorphic form of the citrate of (2S, 3S) -N- (methoxy-5-t-butylphenylmethyl-2-diphenylmethyl-1-azobicice (2.2.2) octan-3-amine (citrate monohydrate) and its pharmaceutical composition ; the pharmaceutical composition of the polymorphic form if the citrate monohydrate has the stability necessary for a formulation to treat emesis; the administration of this pharmaceutical composition is an oral dosage form of immediate release, preferably in the form of a tablet or capsule, or intravenous . |
| priorityDate | 1999-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.